SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BISN - Why the activity
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Volquardsen who wrote (277)4/23/1999 6:19:00 PM
From: tom  Read Replies (1) of 304
 
You're absolutely correct. I'm also involved w/ a company that produces health devices. They also work closely with the FDA, but don't actually want FDA approval for most of their products because of the restrictions upon marketing them. But, the FDA keeps them under strict guidelines. I meant to say that the devices do not have to be FDA approved...unlike many patented drugs.

Having said that, I realize that Biosonics wants the FDA approval for medicare reasons. But, I believe they have already gotten it. FDA approval doesn't mean a hill of beans if they can't market the products. That's why medicare is so important for them. I don't know what the news is, but I would guess it has something to do with Medicare. If it's not medicare, I'm not sure what it is. Maybe they're being bought out. Maybe they are going license one of their products to another company. Whatever it is, I really don't think FDA approval (which I think they've already received) would cause this type of volume.

-Tom
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News